Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome

Effectiveness of Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome: Randomized Double-blind Controlled Clinical Trial.

The purpose of the study is to determine the effectiveness of the treatment with very low frequency magnetic fields (ELF) on the reduction of pain and the relief of the associated signs such as sensitivity disorders that affect the first three fingers and half of the fourth finger of the hand in patients with carpal tunnel syndrome versus the supplement (= Xinepa).

Inclusion Criteria:

• Diagnosis of carpal tunnel syndrome

Exclusion Criteria:

• Pregnancy;
• Pacemaker or other metallic implants;
• Systemic infectious disorders;
• Neoplastic disorders;
• Epilepsy;
• Severe heart disease.
• Known hypersensitivity to the components of Xinepa